Discoidin Domain Receptors: Potential Actors and Targets in Cancer
Open Access
- 14 March 2016
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 7, 55
Abstract
The extracellular matrix critically controls cancer cell behavior by inducing several signaling pathways through cell membrane receptors. Besides conferring structural properties to tissues around the tumor, the extracellular matrix is able to regulate cell proliferation, survival, migration and invasion. Among these receptors, the integrins family constitutes a major class of receptors that mediate cell interactions with extracellular matrix components. Twenty years ago, a new class of extracellular matrix receptors has been discovered. These tyrosine kinase receptors are the two discoidin domain receptors DDR1 and DDR2. DDR1 was first identified in the Dictyostelium discoideum and was shown to mediate cell aggregation. DDR2 shares highly conserved sequences with DDR1. Both receptors are activated upon binding to collagen, one of the most abundant proteins in extracellular matrix. While DDR2 can only be activated by fibrillar collagen, particularly types I and III, DDR1 is mostly activated by type I and IV collagens. In contrast with classical growth factor tyrosine kinase receptors which display a rapid and transient activation, DDR1 and DDR2 are unique in that they exhibit delayed and sustained receptor phosphorylation upon binding to collagen. Recent studies have reported differential expression and mutations of DDR1 and DDR2 in several cancer types and indicate clearly that these receptors have to be taken into account as new players in the different aspects of tumor progression, from non-malignant to highly malignant and invasive stages. This review will discuss the current knowledge on the role DDR1 and DDR2 in malignant transformation, cell proliferation, epithelial to mesenchymal transition, migratory and invasive processes, and finally the modulation of the response to chemotherapy. These new insights suggest that DDR1 and DDR2 are new potential targets in cancer therapy.Keywords
This publication has 110 references indexed in Scilit:
- The collagen receptor discoidin domain receptor 2 stabilizes SNAIL1 to facilitate breast cancer metastasisNature Cell Biology, 2013
- Matrix MetalloproteinasesThe American Journal of Pathology, 2012
- Structure of the Discoidin Domain Receptor 1 Extracellular Region Bound to an Inhibitory Fab Fragment Reveals Features Important for SignalingStructure, 2012
- Discoidin domain receptor tyrosine kinases: new players in cancer progressionCancer and Metastasis Reviews, 2012
- Loss of Discoidin Domain Receptor 2 Promotes Hepatic Fibrosis after Chronic Carbon Tetrachloride through Altered Paracrine Interactions between Hepatic Stellate Cells and Liver-Associated MacrophagesThe American Journal of Pathology, 2011
- Discoidin domain receptor 2 is a critical regulator of epithelial–mesenchymal transitionMatrix Biology, 2011
- Collagen binding specificity of the discoidin domain receptors: Binding sites on collagens II and III and molecular determinants for collagen IV recognition by DDR1Matrix Biology, 2011
- Crystallographic Insight into Collagen Recognition by Discoidin Domain Receptor 2Structure, 2009
- Epithelial-Mesenchymal Transitions in Development and DiseaseCell, 2009
- Mutations in DDR2 Gene Cause SMED with Short Limbs and Abnormal CalcificationsThe American Journal of Human Genetics, 2009